HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sven Brandt Selected Research

ganglidiomab

6/2013Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sven Brandt Research Topics

Disease

8Thrombocytopenia (Thrombopenia)
01/2020 - 10/2012
2Neuroblastoma
01/2016 - 06/2013
2Neoplasms (Cancer)
01/2016 - 06/2013
2Drug-Related Side Effects and Adverse Reactions
11/2015 - 07/2013
1Polyps
11/2015
1Disease Susceptibility (Diathesis)
07/2013
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2013
1Thrombosis (Thrombus)
04/2013

Drug/Important Bio-Agent (IBA)

8Heparin (Liquaemin)FDA LinkGeneric
01/2020 - 10/2012
6AntibodiesIBA
01/2019 - 10/2012
4Platelet Factor 4IBA
01/2020 - 07/2013
2ChemokinesIBA
11/2015 - 07/2013
2Pharmaceutical PreparationsIBA
10/2014 - 10/2012
1Proteins (Proteins, Gene)FDA Link
01/2016
1CoagulantsIBA
11/2015
1Lipid AIBA
11/2015
1PolymersIBA
11/2015
1PolyphosphatesIBA
11/2015
1Immunoglobulin G (IgG)IBA
07/2013
1polyanionsIBA
07/2013
1ganglidiomabIBA
06/2013
1AntigensIBA
06/2013
1Protamines (Protamine Sulfate)FDA Link
04/2013

Therapy/Procedure

1Immunotherapy
06/2013